Xomolix gets a new look
Life has created a new European core campaign for ProStrakan to launch Xomolix (droperidol), which prevents and treats postoperative nausea and vomiting. ProStrakan already markets droperidol in some European countries, but has recently gained marketing authorisations in eight more countries including Germany and the UK.
The campaign reflects the fact that nausea and vomiting is what patients fear the most after surgery, and the imagery shows a 'worried sick' patient in a dramatically queasy setting.
ProStrakan Marketing Director, Richard Tonge said: "Development of the Xomolix® positioning, concept and messaging in a short time would not have been possible without the valuable input of our agency, Life Healthcare...”
You can see the new campaign in our Latest Work section. |
